169 related articles for article (PubMed ID: 33349878)
21. [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].
Chanteau S; Roux JF
Bull Soc Pathol Exot; 2008 Jun; 101(3):254-60. PubMed ID: 18681220
[TBL] [Abstract][Full Text] [Related]
22. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
Hooper PJ; Bradley MH; Biswas G; Ottesen EA
Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394
[TBL] [Abstract][Full Text] [Related]
23. Global programme to eliminate lymphatic filariasis: progress report, 2011.
Wkly Epidemiol Rec; 2012 Sep; 87(37):346-56. PubMed ID: 22977953
[No Abstract] [Full Text] [Related]
24. Global programme to eliminate lymphatic filariasis.
Wkly Epidemiol Rec; 2010 Sep; 85(38):365-72. PubMed ID: 20853547
[No Abstract] [Full Text] [Related]
25. Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India.
Sabesan S; Krishnamoorthy K; Hoti SL; Subramanian S; Srividya A; Roy N; Jain T; Kumar A; Rahi M
Indian J Med Res; 2022 Mar; 155(3&4):347-355. PubMed ID: 36124509
[TBL] [Abstract][Full Text] [Related]
26. Progress in the elimination of lymphatic filariasis in the Western Pacific Region: successes and challenges.
Yajima A; Ichimori K
Int Health; 2020 Dec; 13(Suppl 1):S10-S16. PubMed ID: 33349886
[TBL] [Abstract][Full Text] [Related]
27. The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000-2014).
Turner HC; Bettis AA; Chu BK; McFarland DA; Hooper PJ; Ottesen EA; Bradley MH
Infect Dis Poverty; 2016 May; 5(1):54. PubMed ID: 27388873
[TBL] [Abstract][Full Text] [Related]
28. African regional progress and status of the programme to eliminate lymphatic filariasis: 2000-2020.
Deribe K; Bakajika DK; Zoure HM; Gyapong JO; Molyneux DH; Rebollo MP
Int Health; 2020 Dec; 13(Suppl 1):S22-S27. PubMed ID: 33349875
[TBL] [Abstract][Full Text] [Related]
29. For as Long as Necessary: Examining 30 years of MSD's Focus on Achieving Elimination of Onchocerciasis and Lymphatic Filariasis.
Gustavsen KM; Colatrella BD; McCoy T
Int Health; 2018 Mar; 10(suppl_1):i3-i6. PubMed ID: 29186497
[TBL] [Abstract][Full Text] [Related]
30. Control and elimination of lymphatic filariasis in Oceania: Prevalence, geographical distribution, mass drug administration, and surveillance in Samoa, 1998-2017.
Graves PM; Joseph H; Coutts SP; Mayfield HJ; Maiava F; Ah Leong-Lui TA; Tupuimatagi Toelupe P; Toeaso Iosia V; Loau S; Pemita P; Naseri T; Thomsen R; Berg Soto A; Burkot TR; Wood P; Melrose W; Aratchige P; Capuano C; Kim SH; Ozaki M; Yajima A; Lammie PJ; Ottesen E; Hansell L; Baghirov R; Lau CL; Ichimori K
Adv Parasitol; 2021; 114():27-73. PubMed ID: 34696844
[TBL] [Abstract][Full Text] [Related]
31. How elimination of lymphatic filariasis as a public health problem in the Kingdom of Cambodia was achieved.
Khieu V; Or V; Tep C; Odermatt P; Tsuyuoka R; Char MC; Brady MA; Sidwell J; Yajima A; Huy R; Ramaiah KD; Muth S
Infect Dis Poverty; 2018 Feb; 7(1):15. PubMed ID: 29463307
[TBL] [Abstract][Full Text] [Related]
32. Global programme to eliminate lymphatic filariasis.
Wkly Epidemiol Rec; 2007 Oct; 82(42):361-80. PubMed ID: 17948605
[No Abstract] [Full Text] [Related]
33. Global programme to eliminate lymphatic filariasis: progress report for 2012.
Wkly Epidemiol Rec; 2013 Sep; 88(37):389-99. PubMed ID: 24073461
[No Abstract] [Full Text] [Related]
34. Global Programme to eliminate lymphatic filariasis: progress report on mass drug administration, 2010.
Wkly Epidemiol Rec; 2011 Aug; 86(35):377-88. PubMed ID: 21887884
[No Abstract] [Full Text] [Related]
35. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
[TBL] [Abstract][Full Text] [Related]
36. Progress and impact of 20 years of a lymphatic filariasis elimination programme in South-East Asia.
Kapa DR; Mohamed AJ
Int Health; 2020 Dec; 13(Suppl 1):S17-S21. PubMed ID: 33349881
[TBL] [Abstract][Full Text] [Related]
37. Progress towards elimination of lymphatic filariasis in the Eastern Mediterranean Region.
Ramzy RMR; Al Kubati AS
Int Health; 2020 Dec; 13(Suppl 1):S28-S32. PubMed ID: 33349874
[TBL] [Abstract][Full Text] [Related]
38. Introduction of Triple-Drug Therapy for Accelerating Lymphatic Filariasis Elimination in India: Lessons Learned.
Tripathi B; Roy N; Dhingra N
Am J Trop Med Hyg; 2022 May; 106(5_Suppl):29-38. PubMed ID: 35292580
[TBL] [Abstract][Full Text] [Related]
39. Caring for patients in the global programme to eliminate lymphatic filariasis.
Mackenzie CD; Mante S
Int Health; 2020 Dec; 13(Suppl 1):S48-S54. PubMed ID: 33349884
[TBL] [Abstract][Full Text] [Related]
40. Sustained reduction in prevalence of lymphatic filariasis infection in spite of missed rounds of mass drug administration in an area under mosquito nets for malaria control.
Njenga SM; Mwandawiro CS; Wamae CN; Mukoko DA; Omar AA; Shimada M; Bockarie MJ; Molyneux DH
Parasit Vectors; 2011 May; 4():90. PubMed ID: 21612649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
